Quantcast

ACS develops therapeutic protein that is released when red blood cell carriers are stimulated by light

Protein therapies are often more potent and selective toward their biochemical targets than other types of drugs, particularly small molecules.

Rapid COVID-19 salvia test read by smartphone developed by Tulane researchers

Researchers from Tulane University have developed a 15-minute COVID-19 test that is read by a smartphone to address the need to expand testing capacity in community-based settings.

Latest News

USC study shows sugary drinks interfere with hormones that tell your body its full

Sugary drinks interfere with hormones that tell the body “I feel full,” potentially contributing to obesity and undermining weight loss efforts, a new USC study shows.The findings, which appear today in the Journal of Clinical Endocrinology and Metabolism, strengthen the case against sugar-sweetened beverages, a significant driver of obesity.

Nebraska anglers prove to be more predictable than originally thought

Researchers have found that fishing behavior of Nebraska anglers may be less unpredictable than originally thought, with seven fishing spots in the state seeing little variation from spring to fall.

Parent Project Muscular Dystrophy invests $1 million to fight Duchenne

Parent Project Muscular Dystrophy (PPMD) has invested $1 million in Satellos Bioscience Inc. to help in the development of a regenerative medicine for therapeutic treatment of Duchenne, which the organization helps to fight.

NASA astronauts scheduled for spacewalks

Two NASA astronauts are expected to venture outside to install a European science platform on Wednesday, Jan. 27.

Bioclinica announces new product to help with sensitive patient information

Bioclinica has announced a product to help the redaction of sensitive patient information from videos, photos and PDFs.

Tulane University receives grant for early psychosis studies

Tulane University Department of Psychiatry has been awarded a grant by the National Institute of Mental Health to continue its work on early intervention following an episode of psychosis in a young patient, which can change the outcome.

ASM leadership selects president-elect, board and council members

ASM leadership elected a new president, board and council members, which will start serving their term on July 1, 2021.

Scientists want Congress to approve spending bills to avoid research disruptions

A science group wrote a letter to Congress members on the fiscal year 2021 appropriations and research relief, urging the chambers to complete appropriations bills as soon as possible, so there are no more disruptions to science and research.

MIT students attempting to detect first gravitational waves created in the universe

After the Big Bang, a series of first gravitational waves rippled through the universe, which caused the universe to expand.

Natural disaster plans could help businesses amidst COVID-19 damage

Small and medium businesses have been severely impacted by the COVID-19 pandemic, leaving millions of Americans out of jobs, and researchers at the National Institute of Standards and Technology (NIST) worked with NOAA's Climate Program Office to survey these businesses on the impacts.

Manchester partnership receives AHSC designation for five more years

The partnership between Manchester's NHS and other academic organizations has been given an extension to continue its world-leading health research for diseases, treatments and patient care.

NHS awards grant to University of Utah biomedical engineer for COVID-19 research

Mucus may be part of the spread of the coronavirus and University of Utah biomedical engineer Jessica Kramer has received a grant to research the potential role it plays in spreading the virus.

A4's screening data show link between high amyloid levels and early Alzheimer's disease

Data published from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study on April 6 show that early stages of Alzheimer's disease could be represented by high levels of amyloid protein in the brain.

Studies reveal majority of ventilated COVID-19 patients don't survive

Studies from the U.S., China and Europe have shown that most patients with COVID-19 who need to be put on a ventilator will die and those who survive the illness may need to be on a breathing machine for the rest of their life.